跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
anti-BCMA CAR T-cell therapy (cancer)
首页
药物
anti-BCMA CAR T-cell therapy (cancer)
anti-BCMA CAR T-cell therapy (cancer)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
CHIMERIC ANTIGEN RECEPTORS SPECIFIC TO B-CELL MATURE ANTIGEN (BCMA) AND/OR TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR (TACI)
EP 4590329 A2
申请人: ELPIS BIOPHARMACEUTICALS
优先权: 2022
CN
EP
US
WO
4 件公开
METHOD TO GENERATE IMPROVING CAR-T CELLS
EP 4598565 A1
申请人: INST NAT SANTE RECH MED
优先权: 2022
EP
US
WO
3 件公开
METHODS FOR TREATING MULTIPLE MYELOMA WITH CAR-T CELLS AND BISPECIFIC ANTIBODIES
US 20260041768 A1
申请人: JANSSEN BIOTECH INC
优先权: 2024
US
WO
2 件公开
Combination therapy of ATRA or other retinoic acid with immunotherapeutic agents that bind to BCMA
CN 115667303 A
申请人: UNIV WUERZBURG J MAXIMILIANS
优先权: 2020
CN
ANTI-BCMA SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC CONSTRUCTS
US 20250000976 A1
申请人: NAT RES COUNCIL CANADA
优先权: 2022
US
药物
反馈
